samedan logo
 
 
 
spacer
home > pmps > summer 2018 > bearing life
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bearing Life

The market for bearings is growing, particularly for use in high-accuracy machinery in the pharmaceutical industry. This article explains the impact of radial and thrust forces and what engineers can do to match the right bearing to the load.

The global market for bearings was valued at US $81.6 billion in 2015 and is expected to grow to $172.2 billion by 2025, according to a report by Grand View Research (1). One of the fastest growing subsectors is the miniature ball bearing market − featuring small and miniature bearings with an interior diameter of 9mm or smaller − which is forecast to reach a market value of $2.3 billion by 2026 and expected to increase at a compound annual growth rate of 9% in terms of revenue from 2018-2026 (2).

One key trend is a demand for bearings that can handle the unique challenges posed by chemical and pharma manufacturing and packaging, while still delivering high levels of accuracy, smoothness, and equipment life.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Chris Johnson is Managing Director at SMB Bearings. The Oxfordshire-based company specialises in the supply and relubrication of miniature bearings. Chris has managed operations at the company for over eight years and has made a conscious effort to make it a specialist in miniature, corrosion-resistant, and thin-section bearings. 
spacer
Chris Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer

Patients treated with Lynparza and bevacizumab lived without disease progression for a median of 37.2 months vs. 17.7 months with bevacizumab alone One in two women with advanced ovarian cancer has an HRD-positive tumour
More info >>

White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patientís particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement